Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 29, 2003

View Archived Issues

Drug pipeline for rheumatoid arthritis

GSK designs novel series of glucocorticoids

Akzo Nobel researchers identify new analgesic ORL1 receptor modulators

Inhibitors of HCV RNA replication discovered at Roche

Novel HIV RT inhibitors prepared and tested at Roche

U. of Michigan claims dopamine receptor modulators for cocaine abuse and other disorders

Gabapentin and pregabalin prodrugs designed by XenoPort scientists

Novel glutamate receptor potentiators identified by Lilly research team

Vertex patent covers novel p38 kinase inhibitors

Onyx discontinues development of ONYX-015 to focus on Bay-43-9006

Canvaxin receives fast track designation for metastatic melanoma

Triapine enters further phase II trial in prostate cancer

FM-VP4 safe and well tolerated in phase I study

Elixir signs agreement with UCSF for aging-related research

Discerna joint venture updates progress

First treatment for acute ischemic stroke cleared for use in Europe

Canadian launch announced for the new coxib Bextra

FDA advisory committee to review Vitrase NDA

Genaera focuses development efforts

Magnesium sulfate superior to nimodipine for preventing eclampsia

Improved cardiovascular safety profile found for nesiritide vs. dobutamine in decompensated CHF

T-588 prevents retinal ganglion cell death in rats with elevated IOP

Increase in synaptic density in the brain of aged rats following treatment with FK-960

Kissei presents potent and selective beta3-adrenoceptor agonists for bladder dysfunction

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...